Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FA2VC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,592
Award facts
- Contract value 100% obligated
- $10,591.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CIMZIA 2x200 mg/ml syringe kits valued at $10,591.59 under a firm fixed price contract type. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. CIMZIA is a biologic immunosuppressant medication used in the treatment of rheumatoid arthritis, psoriatic arthritis, and other inflammatory conditions, making this delivery order part of the Defense Health Agency's pharmaceutical supply chain supporting military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp's substantial contract portfolio with the Defense Logistics Agency demonstrates its established capability to meet federal procurement requirements through open competition and its critical role as a primary pharmaceutical distributor for the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FA2VC?
SPE2DB25FA2VC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FA2VC worth?
The government has obligated $10,592 on SPE2DB25FA2VC.
Is contract SPE2DB25FA2VC an order under another contract?
Yes. SPE2DB25FA2VC is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA2VC competed?
The extent of competition for SPE2DB25FA2VC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award